Growth Hormone Fragment
AOD-9604
hGH Fragment 176-191 Lipolytic Peptide
AOD-9604 is a synthetic modified form of the C-terminal fragment of human growth hormone (amino acids 176-191), with the addition of a tyrosine residue at the N-terminus. It was developed with the goal of isolating the lipolytic activity of hGH while avoiding the growth-promoting and insulin-desensitising effects of the full molecule.
Quantity
10MG
FOR LABORATORY RESEARCH USE ONLY — NOT FOR HUMAN CONSUMPTION
Research Information
- C-terminal hGH fragment (176-191) with N-terminal tyrosine modification
- Studied for selective stimulation of lipolysis in adipose tissue research models
- Does not bind to hGH receptor — avoids growth-promoting pathway activation
- Research into fat metabolism pathways without insulin resistance side effects
- Extensively studied in comparison to full hGH in adipose biology research
Storage Conditions
- Long-term: −20°C lyophilised
- Reconstituted: 4°C, use within 28 days
Safe Handling
- For laboratory research use only
- Handle with standard PPE
Frequently Asked
COMPOUND FAQ
Continue Exploring
RELATED COMPOUNDS
Triple Receptor Agonist
Retatrutide
A next-generation triple incretin receptor agonist demonstrating potent multi-receptor activity in preclinical research models.
Reconstitution Solution
BAC Water
Sterile water for injection containing 0.9% benzyl alcohol as a bacteriostatic preservative. The standard reconstitution vehicle for research peptide compounds.
COMING SOON
GLP-1 Agonist
Semaglutide
A long-acting GLP-1 receptor agonist and one of the most extensively studied incretin mimetics, with applications across metabolic, cardiovascular, and neuroendocrine research.
RESEARCH USE ONLY: AOD-9604 is sold exclusively for in vitro laboratory research. Not intended for human or animal consumption. Not for clinical or therapeutic use.